Jolicoeur F B, Rondeau D B, Belanger F, Fouriezos G, Barbeau A
Peptides. 1980 Spring;1(1):103-7. doi: 10.1016/0196-9781(80)90042-x.
Locomotor activity and grooming behavior of rats were recorded for a period of 30 min following intraventricular injections of substance P(SP) in doses of 0.60 and 2.50 microgram/rat. The lower dose of the peptide significantly increased locomotion for 10 min and time spent grooming for 25 min. The effects of the same two doses of SP on the hypokinesia induced by various pharmacological treatments modifying catecholaminergic systems were then examined. SP did not affect the behavioral depression produced by alpha-methyl-para-tyrosine (250 mg/kg), FLA-63 (25 mg/kg) and phenoxybenzamine (20 mg/kg). However, SP, in dose of 0.60 microgram/rat, systematically reversed the decrease in locomotor activity induced by a relatively small dose of haloperidol, 0.1 mg/kg. The dame dose of the peptide significantly counteracted the rigidity but not the hypokinesia and catalepsy resulting from the previous administration of a higher dose of haloperidol, 3 mg/kg. The results support the hypothesis that SP may exert direct or indirect function in motor behavior, possible via a modulatory action on brain dopaminergic systems.
在向大鼠脑室内注射剂量为0.60和2.50微克/只的P物质(SP)后,记录大鼠30分钟的运动活动和梳理行为。较低剂量的该肽显著增加了10分钟的运动能力以及25分钟的梳理时间。然后研究了相同剂量的两种SP对由改变儿茶酚胺能系统的各种药理学处理诱导的运动不能的影响。SP不影响由α-甲基-对酪氨酸(250毫克/千克)、FLA-63(25毫克/千克)和酚苄明(20毫克/千克)产生的行为抑制。然而,剂量为0.60微克/只的SP系统性地逆转了由相对低剂量的氟哌啶醇(0.1毫克/千克)诱导的运动活动减少。相同剂量的该肽显著对抗了先前给予较高剂量氟哌啶醇(3毫克/千克)导致的僵硬,但不能对抗运动不能和僵住症。结果支持以下假设:SP可能在运动行为中发挥直接或间接作用,可能是通过对脑多巴胺能系统的调节作用。